- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02931864
Effects of an e-Home Based Symptom Management and Mindfulness Training Programme on QoL in Breast Cancer Survivors
September 22, 2020 updated by: Karis Cheng, National University of Singapore
Effects of an e-Home Based Symptom Management and Mindfulness Training Programme on Quality of Life in Breast Cancer Survivors
Breast cancer is the most common cancer in women in Singapore.
Breast cancer survivors usually experience side effects/symptoms after surgery and/or adjuvant chemotherapy and/or radiotherapy such as fatigue, lymphedema, problems with sleeping, peripheral neuropathy, and anxiety/depression.
Currently, there is no study to include both symptom management and mindfulness training components for breast cancer survivors.
And given breast cancer survivors have infrequent clinical follow-up, we aim to develop an e-Home based symptom management and mindfulness training programme for breast cancer survivors and to determine its effects on quality of life, symptom distress, psychosocial adjustment, psychological morbidity, and unplanned outpatient attendance or hospitalisation in breast cancer survivors.
We employ a randomised clinical trial with four study arms (with 47 subjects in each arm) together with a process evaluation; group 1 (usual care), group 2 (experimental group: five weekly sessions of online symptom management + mindfulness training programme and usual care), group 3 (comparison group 1: five weekly sessions of online symptom management programme and usual care), and group 4 (comparison group 2: five weekly sessions of online mindfulness training programme and usual care).
Subjects will complete questionnaires measures of 6-item Social Support Questionnaire, Breast Cancer Survivor Self-Efficacy Scale, the Quality of Life-Cancer Survivor Scale, Memorial Symptom Assessment Scale, Psychosocial Adjustment to Illness Scale, short version of the Fear of Recurrence Scale, Hospital and anxiety Depression Scale and Five Facet Mindfulness Questionnaire at baseline (printed questionnaires), at 8 weeks from baseline, at 12 weeks from baseline and at 24 weeks from baseline by an online system or printed questionnaires.
Individualised semi-structured interview (15-25 mins) for experimental and comparison groups will be conducted at 24 weeks from baseline to understand the subjects' experiences of the study programme.
Data will be analysed using SPSS version 24.
Baseline demographic and clinical information of subjects in the experimental, comparison and control groups will be summarised using descriptive statistics, and will be compared using chi square tests and ANOVA/ANCOVA tests.
Intention-to-treat approach will be used.
Repeated measures analysis of variance will be used to examine the differences on outcome measures among the experimental, comparison and control groups across study time points.
In addition, differences in changes in outcome measures among experimental, comparison groups and usual care groups will be tested using multilevel modelling techniques.
A p-value smaller than 5% will be considered as statistically significant.
Content analysis will be conducted to analyse the interviews data.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
172
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Singapore, Singapore
- National University Hospital
-
Singapore, Singapore
- National Cancer Centre Singapore
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- women aged 21 or above
- able to speak and read English
- diagnosed with breast cancer stage 0 to 3 for the first time
- have completed cancer treatment including breast surgery and/or adjuvant chemotherapy and/or radiotherapy between 6 months to 5 years previously
- with and without ongoing HER2 target therapy (e.g.: Herceptin) and/or hormonal therapy
- with ECOG Performance Status score of 0 to 1
- able to understand the study and give informed consent
- have access to the internet through a handheld device
Exclusion Criteria:
- they are illiterate
- have serious psychiatric disorders (e.g. schizophrenia, dementia, and intellectual disabilities)
- with ECOG Performance Status score of 2 or above
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Usual care group
Usual care is meant the routine medical and health care services at the hospital.
|
|
Experimental: Experimental group
Five weekly sessions of online symptom management + mindfulness training programme + usual care
|
5 weekly sessions of online self-administered mindfulness training programme in which they will receive audio-recorded and video-recorded instructions, pictorial or text-based instructions for various mindfulness exercises such as body scan meditation, mindful breathing and walking meditation.
5 weekly online education module in which they will receive video-recorded, audio-recorded, pictorial or text-based instructions for various self-management strategies.
Topics include fatigue, pain, numbness/tingling, lymphedema, anxiety/depression, and problems with sleeping.
|
Active Comparator: Comparison group 1
Five weekly sessions of online symptom management programme + usual care
|
5 weekly online education module in which they will receive video-recorded, audio-recorded, pictorial or text-based instructions for various self-management strategies.
Topics include fatigue, pain, numbness/tingling, lymphedema, anxiety/depression, and problems with sleeping.
|
Active Comparator: Comparison group 2
Five weekly sessions of online mindfulness training programme and usual care
|
5 weekly sessions of online self-administered mindfulness training programme in which they will receive audio-recorded and video-recorded instructions, pictorial or text-based instructions for various mindfulness exercises such as body scan meditation, mindful breathing and walking meditation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change from baseline quality of life score at 8 weeks
Time Frame: Change between baseline and at 8 weeks
|
Change between baseline and at 8 weeks
|
Change from baseline quality of life score at 12 weeks
Time Frame: Change between baseline and at 12 weeks
|
Change between baseline and at 12 weeks
|
Change from baseline quality of life score at 24 weeks
Time Frame: Change between baseline and at 24 weeks
|
Change between baseline and at 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change from baseline social support score at 8 weeks
Time Frame: Change between baseline and at 8 weeks
|
Change between baseline and at 8 weeks
|
Change from baseline social support score at 12 weeks
Time Frame: Change between baseline and at 12 weeks
|
Change between baseline and at 12 weeks
|
Change from baseline social support score at 24 weeks
Time Frame: Change between baseline and at 24 weeks
|
Change between baseline and at 24 weeks
|
Change from baseline self-efficacy score at 8 weeks
Time Frame: Change between baseline and at 8 weeks
|
Change between baseline and at 8 weeks
|
Change from baseline self-efficacy score at 12 weeks
Time Frame: Change between baseline and at 12 weeks
|
Change between baseline and at 12 weeks
|
Change from baseline self-efficacy score at 24 weeks
Time Frame: Change between baseline and at 24 weeks
|
Change between baseline and at 24 weeks
|
Change from baseline symptom score at 8 weeks
Time Frame: Change between baseline and at 8 weeks
|
Change between baseline and at 8 weeks
|
Change from baseline symptom score at 12 weeks
Time Frame: Change between baseline and at 12 weeks
|
Change between baseline and at 12 weeks
|
Change from baseline symptom score at 24 weeks
Time Frame: Change between baseline and at 24 weeks
|
Change between baseline and at 24 weeks
|
Change from baseline psychosocial adjustment to illness score at 8 weeks
Time Frame: Change between baseline and at 8 weeks
|
Change between baseline and at 8 weeks
|
Change from baseline psychosocial adjustment to illness score at 12 weeks
Time Frame: Change between baseline and at 12 weeks
|
Change between baseline and at 12 weeks
|
Change from baseline psychosocial adjustment to illness score at 24 weeks
Time Frame: Change between baseline and at 24 weeks
|
Change between baseline and at 24 weeks
|
Change from baseline fear of recurrence score at 8 weeks
Time Frame: Change between baseline and at 8 weeks
|
Change between baseline and at 8 weeks
|
Change from baseline fear of recurrence score at 12 weeks
Time Frame: Change between baseline and at 12 weeks
|
Change between baseline and at 12 weeks
|
Change from baseline fear of recurrence score at 24 weeks
Time Frame: Change between baseline and at 24 weeks
|
Change between baseline and at 24 weeks
|
Change from baseline anxiety and depression score at 8 weeks
Time Frame: Change between baseline and at 8 weeks
|
Change between baseline and at 8 weeks
|
Change from baseline anxiety and depression score at 12 weeks
Time Frame: Change between baseline and at 12 weeks
|
Change between baseline and at 12 weeks
|
Change from baseline anxiety and depression score at 24 weeks
Time Frame: Change between baseline and at 24 weeks
|
Change between baseline and at 24 weeks
|
Change from baseline mindfulness score at 8 weeks
Time Frame: Change between baseline and at 8 weeks
|
Change between baseline and at 8 weeks
|
Change from baseline mindfulness score at 12 weeks
Time Frame: Change between baseline and at 12 weeks
|
Change between baseline and at 12 weeks
|
Change from baseline mindfulness score at 24 weeks
Time Frame: Change between baseline and at 24 weeks
|
Change between baseline and at 24 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Karis Cheng, National University of Singapore
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
- Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994;30A(9):1326-36. doi: 10.1016/0959-8049(94)90182-1.
- Baer RA, Smith GT, Hopkins J, Krietemeyer J, Toney L. Using self-report assessment methods to explore facets of mindfulness. Assessment. 2006 Mar;13(1):27-45. doi: 10.1177/1073191105283504.
- Bower JE, Ganz PA, Desmond KA, Bernaards C, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer. 2006 Feb 15;106(4):751-8. doi: 10.1002/cncr.21671.
- Champion VL, Ziner KW, Monahan PO, Stump TE, Cella D, Smith LG, Bell CJ, Von Ah D, Sledge GW. Development and psychometric testing of a breast cancer survivor self-efficacy scale. Oncol Nurs Forum. 2013 Nov;40(6):E403-10. doi: 10.1188/13.ONF.E403-E410.
- Ferrell BR, Dow KH, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res. 1995 Dec;4(6):523-31. doi: 10.1007/BF00634747.
- Cheng KK, Darshini Devi R, Wong WH, Koh C. Perceived symptoms and the supportive care needs of breast cancer survivors six months to five years post-treatment period. Eur J Oncol Nurs. 2014 Feb;18(1):3-9. doi: 10.1016/j.ejon.2013.10.005. Epub 2013 Dec 5.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 6, 2016
Primary Completion (Actual)
March 14, 2020
Study Completion (Actual)
March 14, 2020
Study Registration Dates
First Submitted
October 10, 2016
First Submitted That Met QC Criteria
October 11, 2016
First Posted (Estimate)
October 13, 2016
Study Record Updates
Last Update Posted (Actual)
September 23, 2020
Last Update Submitted That Met QC Criteria
September 22, 2020
Last Verified
September 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R-545-000-073-592
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Children's National Research InstituteRecruitingProfessional Quality of LifeUnited States
-
Istituto Ortopedico RizzoliUniversity of BolognaActive, not recruitingImprove Quality of LifeItaly
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
-
Linkoeping UniversityRecruiting
-
South Valley UniversityActive, not recruitingDeterminants of Health-related Quality of Life for Patients After Renal Lithotripsy: PNL Versus RIRSHealth Related Quality of LifeEgypt
-
Region VästmanlandUnknownHealth Related Quality of Life
Clinical Trials on Online mindfulness training
-
Masaryk UniversityMasaryk Memorial Cancer InstituteRecruiting
-
Masaryk UniversityMasaryk Memorial Cancer InstituteRecruitingBreast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage IIICzechia
-
University of California, San FranciscoGenentech, Inc.CompletedCaregiver | Metastatic Gastrointestinal CarcinomaUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingColorectal CarcinomaUnited States
-
University of SurreySurrey and Borders Partnership NHS Foundation Trust; First Community Health...Completed
-
University of Southern CaliforniaCompleted
-
Chinese University of Hong KongWithdrawn
-
National Taipei University of Nursing and Health...Recruiting
-
University of Vic - Central University of CataloniaRecruitingMultiple SclerosisSpain
-
Florida State UniversityCompletedPain, Postoperative | Chronic Pain | Pain, Acute | Pain CatastrophizingUnited States